— Know what they know.
Not Investment Advice

ISPC NASDAQ

iSpecimen Inc.
1W: -17.5% 1M: -30.2% 3M: -59.5% YTD: -90.9% 1Y: -97.9% 3Y: -99.8% 5Y: -100.0%
$1.08
-0.06 (-5.26%)
 
Weekly Expected Move ±7.9%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 30 · $2.7M mcap · 3M float · 21.01% daily turnover · Short 26% of daily vol

Cash Flow Trends

Operating Cash Flow
-$8M -42.3% ▼
Capital Expenditures
$57K +98.8% ▲
5Y CAGR: -47.9%
Free Cash Flow
-$8M +21.4% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$465K +96.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$5M-$9M-$10M-$11M-$12M
Depreciation & Amort.$820K$1M$1M$2M$2M
Stock-Based Comp.$93K$622K$679K$460K$250K
Change in Working Capital$3M-$5M$2M$3M-$503K
Other Non-Cash Items$411K$2M$190K$128K$2M
Operating Cash Flow-$288K-$11M-$6M-$6M-$8M
— Investing Activities —
Capital Expenditures-$426-$3K-$216K-$19K-$32K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0-$13M-$461K
Investment Sales$0$0$0$11M$3M
Other Investing-$1M-$1M-$3M-$5M-$678K
Investing Cash Flow-$1M-$1M-$3M-$7M$2M
— Financing Activities —
Net Debt Issuance$2M$1M-$4M$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0-$4M$79K$71K$4M
Financing Cash Flow$2M$39M-$3M$71K$6M
Net Change in Cash$642K$27M-$12M-$13M-$465K
Cash End of Period$696K$28M$15M$2M$2M
Free Cash Flow-$1M-$12M-$9M-$11M-$8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms